BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02521051-completion@plaintrial.com
DTSTAMP:20260928T082545Z
DTSTART;VALUE=DATE:202204
SUMMARY:Phase I/II Trial of Alectinib and Bevacizumab in Patients With Adva
 nced\, Anaplastic Lymphoma Kinase (ALK)-Positive\, Non-Small Cell Lung Can
 cer — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT02521051
URL:https://plaintrial.com/trial/NCT02521051
END:VEVENT
END:VCALENDAR